Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Senthilnathan Palaniyandi"'
Autor:
Drew R. Nannini, Rene Cortese, Peter Egwom, Senthilnathan Palaniyandi, Gerhard C. Hildebrandt
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-8 (2023)
Abstract Chronic lymphocytic leukemia (CLL) is a mature B cell neoplasm with a predilection for older individuals. While previous studies have identified epigenetic signatures associated with CLL, whether age-related DNA methylation changes modulate
Externí odkaz:
https://doaj.org/article/13f798d1cf85400a900e08a789e82a78
Publikováno v:
HemaSphere, Vol 7, p e22000bd (2023)
Externí odkaz:
https://doaj.org/article/a49756fede224bd1bccca7d6386badbc
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the solitary therapeutic therapy for many types of hematological cancers. The benefits of this procedure are challenged by graft vs. host disease (GVHD), causing significant morbidity and m
Externí odkaz:
https://doaj.org/article/5ef8bd8c1be44be49f0356645805bf88
Autor:
Ethan Strattan, Senthilnathan Palaniyandi, Reena Kumari, Jing Du, Natalya Hakim, Timothy Huang, Melissa V. Kesler, C. Darrell Jennings, Jamie L. Sturgill, Gerhard C. Hildebrandt
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is often used to treat acute leukemia or defects of hematopoiesis. Its widespread use is hampered by graft-vs.-host disease (GVHD), which has high morbidity and mortality in both acute and chr
Externí odkaz:
https://doaj.org/article/a4a925a985e64d83a1dbfdad6c855820
Autor:
Senthilnathan Palaniyandi, Sabarinath Venniyil Radhakrishnan, Fridrik J Karlsson, Karen Y Stokes, Nicolai Kittan, Elisabeth Huber, Gerhard C Hildebrandt
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61841 (2013)
The success of allogeneic (allo) hematopoietic cell transplantation (HCT) is limited by its treatment related complications, mostly graft versus host disease (GVHD) and fungal and viral infections. CMV reactivation after HCT has been associated with
Externí odkaz:
https://doaj.org/article/39341d2905e84c11844068f0d039a0a4
Autor:
Gerhard C. Hildebrandt, Ethan Strattan, Natalya Hakim, Senthilnathan Palaniyandi, Melissa Kesler, Reinhold Munker, Reena Kumari, Sabarinath Venniyil Radhakrishnan
Publikováno v:
Transplantation
BACKGROUND. Prolyl hydroxylase inhibitors (PHI) promote stabilization of hypoxia-inducible factor-1 alpha and affect signaling cascades of inflammation and cell death. Their beneficial use in experimental models of ulcerative colitis and lung allogra
Autor:
Senthilnathan Palaniyandi, Ethan Strattan, Reena Kumari, Natalya Hakim, Melissa Kesler, Mutiah Apatira, Fabiola Bittencourt, Longcheng Wang, Zhaozhong Jia, Tarikere Gururaja, Ronald Hill, Gerhard C. Hildebrandt
Publikováno v:
Transplantation and Cellular Therapy. 28:S279-S280
Autor:
Reinhold Munker, Jessica N. Cox, Gerhard C. Hildebrandt, Roger H. Herzig, Salahuddin Siddiqui, Senthilnathan Palaniyandi
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 150, Iss 3, Pp 221-227 (2019)
Indian Journal of Medical Research, Vol 150, Iss 3, Pp 221-227 (2019)
Anti-thymocyte globulin (ATG) is a polyclonal antiserum introduced into clinical medicine more than 30 years ago. It induces a broad non-specific immunosuppression. In haematology, standard indications are severe aplastic anaemia and prophylaxis and
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
Allogeneic hematopoietic stem cell transplantation (HSCT) is the solitary therapeutic therapy for many types of hematological cancers. The benefits of this procedure are challenged by graft vs. host disease (GVHD), causing significant morbidity and m
Autor:
Reena Kumari, Audrey Law, Bara Naji Hamdi Alzghoul, Ethan Strattan, Timothy Huang, Luke Moe, Senthilnathan Palaniyandi, Gerhard C. Hildebrandt
Publikováno v:
Transplantation and Cellular Therapy. 28:S316